• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AMS SPECTRA CONCEALABLE PENILE PROSTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AMS SPECTRA CONCEALABLE PENILE PROSTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720074-02
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 12/21/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient had the spectra penile prosthesis removed due to an infection.A new tactra penile prosthesis was implanted.Following the surgery, the patient was stable and the event resolved.
 
Additional Manufacturer Narrative
Investigation summary: based on the information available, the cause that contributed to the reported infection could not be established as the product is not available for analysis.Device history record review (dhr): the device history record review (dhr) confirmed that the device met all material, assembly and performance specifications.A risk review confirmed that the event is accounted for in the risk documentation.Device technical analysis: the device was not available for analysis; therefore, no physical or visual analysis of the product could be performed.Labeling review: a review of the device instructions for use (ifu) was completed and did not review any evidence of device off-label use or failure to follow instructions.Infection is documented as adverse events.Investigation conclusion: based on this investigation and all information available, a conclusion code of known inherent risk of device was assigned to this investigation.Risk review and labeling review identified that the adverse event of infection is a known risk of the device.The cause of the infection was not established by physician, although infection is included in the labelling documentation for infection device as an adverse event of implant surgical procedure of device and also the risks, benefits, and potential adverse events of all available treatment options should be discussed with the patient and considered by the physician and patient when choosing a treatment option is included in the document, therefore a conclusion code of known inherent risk of device was chosen.
 
Event or Problem Description
It was reported that the patient had the spectra penile prosthesis removed due to an infection.A new tactra penile prosthesis was implanted.Following the surgery, the patient was stable and the event resolved.
 
Additional Manufacturer Narrative
Investigation summary: with all the available information, boston scientific concludes, based on analysis results, the cause that contributed to the infection issue was not confirmed.Device history record review (dhr): the device history record review (dhr) confirmed that the device met all material, assembly and performance specifications.Review of the manufacturing records found no evidence that the device failed to meet applicable product specifications prior to shipment from boston scientific.Additionally, the reported events do not contain an allegation against the labeling.Device technical analysis: upon receipt at our post market quality assurance laboratory, this device was thoroughly analyzed.The spectra penile prosthesis (spp) cylinders were visually inspected, microscope examined and functionally tested and no visual damages were found upon inspection.Both cylinders passed the bend test with a force readout of less than 1390 grams.The cylinders, therefore, performed within specification.Product analysis was unable to confirm the reported events.Labeling review: a labeling review was performed and according to the app instruction for use document, infection is documented as an adverse event.Also, there is no evidence that the device was used or handled improperly.Investigation conclusion: based on this investigation a clear probable cause for the event was established; therefore, the investigation conclusion code of known inherent risk of device was chosen, as infection is included in the product labeling and hazard analysis.
 
Event or Problem Description
It was reported that the patient had the spectra penile prosthesis removed due to an infection.A new tactra penile prosthesis was implanted.Following the surgery, the patient was stable and the event resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMS SPECTRA CONCEALABLE PENILE PROSTHESIS
Common Device Name
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer Contact
alyson harris
4100 hamline avenue north
building c
saint paul, MN 55112
4089353452
MDR Report Key13100392
Report Number2124215-2021-38927
Device Sequence Number2047766
Product Code FAE
UDI-Device Identifier00878953005287
UDI-Public00878953005287
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K090663
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date11/08/2021
Device Model Number720074-02
Device Catalogue Number720074-02
Device Lot Number0155876001
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/31/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/22/2021
Supplement Date Received by Manufacturer01/07/2022
02/04/2022
Initial Report FDA Received Date12/28/2021
Supplement Report FDA Received Date01/28/2022
02/25/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/08/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age76 YR
Patient SexMale
-
-